Recent Advances in Genetic Testing and Clinical Management of Hereditary Breast and Ovarian Cancer (HBOC) in India
Cancer Medicine · 2026-07 · 15 (7)
DOI: 10.1002/cam4.71497 ↗At a glance
Übersichtsarbeit in Cancer Medicine, published online on 2026-07-24. Written by Prathika Sherigar and 4 co-authors. Institution: Department of Medical Oncology, Manipal Comprehensive Cancer Care Centre, Kasturba Medical College (KMC), Manipal Academy of Higher Education, Manipa…. Major MEDLINE topics: Genetic Testing, Hereditary Breast and Ovarian Cancer Syndrome. 121 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Background Hereditary breast and ovarian cancer (HBOC) syndromes, responsible for 5%–10% of all breast and ovarian cancers in the general population, are largely associated with pathogenic variants of the BRCA1 and BRCA2 genes. Yet, the role of other cancer susceptibility genes highlights the genetic etiology of HBOC as complex, thus requiring thorough investigation beyond these main mutations, highlighting a need for a comprehensive genetic assessment in disease management strategies. Summary In India, advances in genetic research and clinical management have significantly impacted the knowledge of HBOC. A definitive prevalence of BRCA1 /2 mutations among Indian populations has catalyzed the adoption of genetic counseling for precision diagnosis and treatment strategies in recent times, with collateral support extended from communities among oncologists, geneticists, and reproductive medicine specialists. The integration of next‐generation sequencing and multiplex gene panels creates a platform for identifying high‐risk subjects, leading to individualized care pathways and enhanced disease management plans. These programs have increased access to essential services such as genetic counseling, multidisciplinary management, and fertility preservation to provide holistic care to HBOC patients. Key Message Future efforts should explore further the genetic heterogeneity of HBOC in Indian populations. There needs to be wider access to genetic testing and counseling services, and the implementation of strong, ethical policy guidelines for equitable use of genetic information. Through the creation of innovative, collaborative methods, these measures have tremendous potential to improve patient care, early detection, and outcomes for individuals affected by HBOC in India.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Medical Oncology, Manipal Comprehensive Cancer Care Centre, Kasturba Medical College (KMC), Manipal Academy of Higher Education, Manipal, Karnataka, India.
- Department of Public Health Genomics, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India.
ORCID profiles: Srikrishna Kedlaya Herga, Sharada Mailankody, Karthik S Udupa
Cite
APA
Sherigar, P., Kedlaya Herga, S., Pai, A., Mailankody, S., & Udupa, K. S. (2026). Recent Advances in Genetic Testing and Clinical Management of Hereditary Breast and Ovarian Cancer (HBOC) in India. Cancer Medicine, 15(7). https://doi.org/10.1002/cam4.71497
Vancouver
Sherigar P, Kedlaya Herga S, Pai A, Mailankody S, Udupa KS. Recent Advances in Genetic Testing and Clinical Management of Hereditary Breast and Ovarian Cancer (HBOC) in India. Cancer Medicine. 2026;15(7). doi:10.1002/cam4.71497
BibTeX
@article{Sherigar2026,
author = {Sherigar, Prathika and Kedlaya Herga, Srikrishna and Pai, Ananth and Mailankody, Sharada and Udupa, Karthik S},
title = {Recent Advances in Genetic Testing and Clinical Management of Hereditary Breast and Ovarian Cancer (HBOC) in India},
journal = {Cancer Medicine},
year = {2026},
volume = {15},
number = {7},
doi = {10.1002/cam4.71497}
}
EUVIMED